QQ客服 官方微博 反馈留言

	Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
	Shi, Tingyan; Wang, Pan; Tang, Wenbin; Jiang, Rong; Yin, Sheng; Shi, Di; Wang, Qing; Wei, Qingyi; Zang, Rongyu
刊名	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
	2018
卷号	47期号:5
关键词	Ovarian cancer BRCA1 gene BRCA2 gene Mutation Survival Residual disease
ISSN号	1015-8987
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3608710
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Shi, Tingyan,Wang, Pan,Tang, Wenbin,et al. Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer[J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,2018,47(5).
APA	Shi, Tingyan.,Wang, Pan.,Tang, Wenbin.,Jiang, Rong.,Yin, Sheng.,...&Zang, Rongyu.(2018).Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer.CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,47(5).
MLA	Shi, Tingyan,et al."Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer".CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 47.5(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。